These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22144322)

  • 1. Investigation of astrocyte - oligodendrocyte interactions in human cultures.
    John GR
    Methods Mol Biol; 2012; 814():401-14. PubMed ID: 22144322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter astrocytes in health and disease.
    Lundgaard I; Osório MJ; Kress BT; Sanggaard S; Nedergaard M
    Neuroscience; 2014 Sep; 276():161-73. PubMed ID: 24231735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axon-oligodendrocyte interactions during developmental myelination, demyelination and repair.
    Piaton G; Gould RM; Lubetzki C
    J Neurochem; 2010 Sep; 114(5):1243-60. PubMed ID: 20524961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro assay to examine oligodendrocyte precursor cell migration on astrocytes.
    Afshari FT; Fawcett JW
    Methods Mol Biol; 2012; 814():393-9. PubMed ID: 22144321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation.
    Zhang Y; Taveggia C; Melendez-Vasquez C; Einheber S; Raine CS; Salzer JL; Brosnan CF; John GR
    J Neurosci; 2006 Nov; 26(47):12174-85. PubMed ID: 17122042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of remyelination: recent insight from experimental models.
    Tanaka T; Yoshida S
    Biomol Concepts; 2014 Aug; 5(4):289-98. PubMed ID: 25372760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocytes induce oligodendrocyte processes to align with and adhere to axons.
    Meyer-Franke A; Shen S; Barres BA
    Mol Cell Neurosci; 1999; 14(4-5):385-97. PubMed ID: 10588392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination.
    Patel JR; McCandless EE; Dorsey D; Klein RS
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11062-7. PubMed ID: 20534485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to make an oligodendrocyte.
    Goldman SA; Kuypers NJ
    Development; 2015 Dec; 142(23):3983-95. PubMed ID: 26628089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytes--friends or foes in multiple sclerosis?
    Williams A; Piaton G; Lubetzki C
    Glia; 2007 Oct; 55(13):1300-12. PubMed ID: 17626262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of oligodendrocyte proliferation and remyelination after chronic demyelination. Relevance to multiple sclerosis.
    Raine CS; Moore GR; Hintzen R; Traugott U
    Lab Invest; 1988 Oct; 59(4):467-76. PubMed ID: 2459499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.
    Miron VE; Ludwin SK; Darlington PJ; Jarjour AA; Soliven B; Kennedy TE; Antel JP
    Am J Pathol; 2010 Jun; 176(6):2682-94. PubMed ID: 20413685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactive astrocytes inhibit the survival and differentiation of oligodendrocyte precursor cells by secreted TNF-α.
    Su Z; Yuan Y; Chen J; Zhu Y; Qiu Y; Zhu F; Huang A; He C
    J Neurotrauma; 2011 Jun; 28(6):1089-100. PubMed ID: 21309692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.
    Alizadeh A; Karimi-Abdolrezaee S
    J Physiol; 2016 Jul; 594(13):3539-52. PubMed ID: 26857216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To what extent is oligodendrocyte progenitor migration a limiting factor in the remyelination of multiple sclerosis lesions?
    Franklin RJ; Blakemore WF
    Mult Scler; 1997 Apr; 3(2):84-7. PubMed ID: 9291159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.
    Watzlawik JO; Warrington AE; Rodriguez M
    PLoS One; 2013; 8(2):e55149. PubMed ID: 23383310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
    Mohan H; Friese A; Albrecht S; Krumbholz M; Elliott CL; Arthur A; Menon R; Farina C; Junker A; Stadelmann C; Barnett SC; Huitinga I; Wekerle H; Hohlfeld R; Lassmann H; Kuhlmann T; Linington C; Meinl E
    Acta Neuropathol Commun; 2014 Dec; 2():168. PubMed ID: 25589163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting myelin repair and return of function in multiple sclerosis.
    Zhang J; Kramer EG; Asp L; Dutta DJ; Navrazhina K; Pham T; Mariani JN; Argaw AT; Melendez-Vasquez CV; John GR
    FEBS Lett; 2011 Dec; 585(23):3813-20. PubMed ID: 21864535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.